The University of Chicago Header Logo

Connection

Blase Polite to Ipilimumab

Back to Details
This is a "connection" page, showing publications Blase Polite has written about Ipilimumab.
Blase Polite
Connection Strength
0.229
Ipilimumab
  1. NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. J Clin Oncol. 2026 Feb 20; 44(6):497-507.
    View in: PubMed
    Score: 0.229
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.